Abstract
Cabozantinib inhibits receptor tyrosine kinases involved in tumor angiogenesis and metastasis. The capsule formulation (Cometriq((R))) is approved for......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
